{
    "title": "Individual feed for https://search.cnbc.com/rs/search/combinedcms/view.xml?partnerId=wrss01&id=15839069",
    "link": "https://search.cnbc.com/rs/search/combinedcms/view.xml?partnerId=wrss01&id=15839069",
    "description": "Individual feed output.",
    "lastBuildDate": "2026-01-23T17:10:58.501567",
    "items": [
        {
            "title": "Flocking to precious metal ETFs? Keep an eye out for these tax surprises",
            "link": "https://www.cnbc.com/2026/01/23/flocking-to-precious-metal-etfs-watch-for-these-tax-surprises.html",
            "description": "Precious metals are rallying, but investors who are buying into the trade could be in for some tax complexity.",
            "pubDate": "2026-01-23T20:31:19",
            "image_url": "https://lead-mark.github.io/snippets/genNewsImagesTwo/Picture5.png"
        },
        {
            "title": "Intel's likely to still move higher. Here's a 'no-cost' options strategy to play it",
            "link": "https://www.cnbc.com/2026/01/23/intels-likely-to-still-move-higher-heres-a-no-cost-options-strategy-to-play-it-.html",
            "description": "Intel is an essential name to the U.S. economy and the \"Soprano-like\" equity ownership by the government makes me want to own this company for the lon...",
            "pubDate": "2026-01-23T16:56:59",
            "image_url": "https://lead-mark.github.io/snippets/genNewsImagesTwo/Picture3.png"
        },
        {
            "title": "JPMorgan upgrades consumer goods stock on confidence in second-half acceleration",
            "link": "https://www.cnbc.com/2026/01/23/jpmorgan-upgrades-consumer-goods-stock-citing-expected-2h-acceleration.html",
            "description": "JPMorgan sees shares of Procter & Gamble rising 11% from current levels.",
            "pubDate": "2026-01-23T16:54:46",
            "image_url": "https://lead-mark.github.io/snippets/genNewsImagesTwo/Picture3.png"
        },
        {
            "title": "Roth says this biopharma stock has room to run on drug momentum, upcoming trial catalysts",
            "link": "https://www.cnbc.com/2026/01/23/roth-says-this-biopharma-stock-has-room-to-run-on-drug-momentum-upcoming-trial-catalysts.html",
            "description": "Roth's $212 price target implies an additional upside of 32% for shares of Insmed, which have already rallied 160% in the last 12 months.",
            "pubDate": "2026-01-23T16:52:22",
            "image_url": "https://lead-mark.github.io/snippets/genNewsImagesTwo/Picture5.png"
        },
        {
            "title": "Intel’s earnings beat couldn’t offset a weaker-than-expected outlook. Here’s what analysts are saying",
            "link": "https://www.cnbc.com/2026/01/23/intels-earnings-beat-couldnt-offset-a-weaker-than-expected-outlook-heres-what-analysts-are-saying.html",
            "description": "For the most part, Wall Street analysts maintained a hold-equivalent rating on Intel after supply constraints weighed on the company's current-quarter...",
            "pubDate": "2026-01-23T16:47:26",
            "image_url": "https://lead-mark.github.io/snippets/genNewsImagesTwo/Picture9.png"
        }
    ]
}